FDAnews
www.fdanews.com/articles/82154-bayer-spins-off-anti-infectives-unit-into-co-in-which-santo-holds-majority-stake

BAYER SPINS OFF ANTI-INFECTIVES UNIT INTO CO IN WHICH SANTO HOLDS MAJORITY STAKE

November 3, 2005

Bayer AG said it plans to spin off its anti-infectives research unit into a new company in which Stuttgart-based Santo Holding Deutschland AG will own a majority holding. Bayer will retain a minority holding. The transaction will be completed in the first quarter of 2006. No financial details were disclosed. The research fields covered by the unit include human cytomegalovirus, hepatitis C, HIV, herpes and gram-positive bacteria.
Forbes